Inventor · disambiguated record
Tehila Ben-Moshe
Also filed as: BEN-MOSHE TEHILA
13 granted patents·14 pending applications·32 citations·filing 2010–2025
89Inventor score
Top patents by PatentIndex Score
27 records- 0188US11866509B2Humanized antibodies against CEACAM1FAMEWAVE LTD·Filed 2020·Granted Jan 9, 2024·2 cites·18 claims
- 0288US11236162B2Antibodies against ILT2BIOND BIOLOGICS LTD·Filed 2021·Granted Feb 1, 2022·2 cites·14 claims
- 0387US10870842B2Stabilized alpha-galactosidase and uses thereofPROTALIX LTD·Filed 2019·Granted Dec 22, 2020·2 cites·20 claims
- 0484US9194011B2Stabilized alpha-galactosidase and uses thereofSHULMAN AVIDOR·Filed 2011·Granted Nov 24, 2015·8 cites·41 claims
- 0582US10280414B2Stabilized α-galactosidase and uses thereofPROTALIX LTD·Filed 2017·Granted May 7, 2019·3 cites·20 claims
- 0681US10081679B2Compositions comprising anti-CEACAM1 and anti-PD antibodies for cancer therapyCCAM BIOTHERAPEUTICS LTD·Filed 2014·Granted Sep 25, 2018·10 cites·18 claims
- 0780US12071479B2Antibodies against ILT2 and use thereofBIOND BIOLOGICS LTD·Filed 2021·Granted Aug 27, 2024·1 cites·23 claims
- 0879US12385026B2Stabilized alpha-galactosidase and uses thereofPROTALIX LTD·Filed 2022·Granted Aug 12, 2025·0 cites·16 claims
- 0978US10550196B2Humanized antibodies against CEACAM1CCAM BIOTHERAPEUTICS LTD·Filed 2015·Granted Feb 4, 2020·3 cites·16 claims
- 1077US12139534B2Methods and compositions for decreasing soluble immune receptor CD28BIOND BIOLOGICS LTD·Filed 2019·Granted Nov 12, 2024·1 cites·10 claims
- 1176US2024309094A1Methods and compositions for decreasing soluble immune receptor cd28BIOND BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1275US2025388668A1Antibodies against ilt2 and use thereofBIOND BIOLOGICS LTD·Filed 2025·Application pending·0 cites
- 1369US12391755B2Methods of use for anti-ILT2 antibodiesBIOND BIOLOGICS LTD·Filed 2021·Granted Aug 19, 2025·0 cites·20 claims
- 1462US2024092934A1Assessment of ceacam1 expression on tumor infiltrating lymphocytesFAMEWAVE LTD·Filed 2023·Application pending·0 cites
- 1561US2025019441A1Treatment of cancer with anti-ilt2 antibodiesBIOND BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1659US2025277032A1Anti-ilt3 antibodies and use thereofBIOND BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 1758US2023221325A1Soluble cd28 levels after immunotherapyBIOND BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 1857US11427647B2Polynucleotides encoding humanized antibodies against CEACAM1FAMEWAVE LTD·Filed 2019·Granted Aug 30, 2022·0 cites·19 claims
- 1957US2024350648A1Intracellular delivery compositionsBIOND BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 2056US2024279335A1Cd28 shedding blocking agentsBIOND BIOLOGICS LTD·Filed 2022·Application pending·0 cites
- 2151US2024010706A1Immunomodulatory compostions and use thereofBIOND BIOLOGICS LTD·Filed 2021·Application pending·0 cites
- 2248US2023035730A1Soluble cd28 levels during immunotherapyBIOND BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 2348US2023041599A1Use of mmp inhibitionBIOND BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 2447US12503510B2Small shedding blocking agentsBIOND BIOLOGICS LTD·Filed 2020·Granted Dec 23, 2025·0 cites·20 claims
- 2546US2022153845A1A method for immunosuppressionBIOND BIOLOGICS LTD·Filed 2020·Application pending·0 cites
- 2640US2013017169A1Multimeric forms of therapeutic proteins and uses thereofPROTALIX LTD·Filed 2011·Application pending·0 cites
- 2734US2012230974A1Alkaline alpha galactosidase for the treatment of fabry diseaseSHAALTIEL YOSEPH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tehila Ben-Moshe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →